scorecardresearch
Add as a preferred source on Google
Thursday, February 19, 2026
TopicSpinal Muscular Atrophy

Topic: Spinal Muscular Atrophy

Roche patent case: Why SC refused to halt Natco’s generic spinal muscular atrophy drug Risdiplam

Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with its petition.

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

New hope for rare disease patients: Rs 900-cr govt project to get high-value drugs at lower rates in works

India has 8.4 to 19 crore rare disease patients, according to health ministry estimates. But current beneficiaries in most cases are kids or those who need relatively less expensive drugs.

On Camera

Andrew Mountbatten-Windsor has debts to pay

London: Just when you thought former prince Andrew Mountbatten-Windsor could sink no lower, fresh evidence shows that indeed he did. King Charles’ troublesome younger brother...

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

US military commander, envoy Sergio Gor visit Indian Army Western Command, Bengaluru next

At the Western Army Command, the American delegation was briefed on the capabilities of the formation, past operations and the path ahead.

The new Great Game—Trump’s playing for time, China for leverage & India for wiggle room

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.